ZenBio, Inc. was founded in 1995 to meet the urgent need of investigators interested in understanding human obesity, diabetes and cardiovascular disease. While rodent models are useful for deciphering metabolic pathways of energy partitioning, the critical analyses for drug development in humans requires an appropriate in vitro model to study human adipocytes. Being a pioneer in adipose-derived stem cells (ASCs), ZenBio continues this legacy providing cutting edge human primary cell culture products and services. Their wide range of cell systems include blood derivatives, adipocytes, stem cells, hepatocytes and many other human primary cells types. Both normal and disease state material can be sourced.